Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ross Southworth

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2003
Treatment options for acute decompensated heart failureMary Ross Southworth
Therapeutic Innovation & Regulatory Science|September 21, 2018
Just Say No?Mary Ross Southworth, Norman Stockbridge
Therapeutic Innovation & Regulatory Science|March 15, 2026
Letter to the Editor: Battle Won but War Lost for Barth Syndrome PatientsNorman Stockbridge, Mary Ross Southworth
The New England Journal of Medicine|November 12, 2010
Interaction of clopidogrel and omeprazoleMary Ross Southworth, Robert Temple
The Journal of Cardiovascular Nursing|November 6, 2004
New treatment option for heart failure patients: eplerenoneMary Ross Southworth, Larisa H Cavallari
Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2019
Real World Data and Evidence: Support for Drug Approval: Applications to Kidney DiseasesAliza M Thompson, Mary Ross Southworth
Annals of Internal Medicine|March 19, 2008
Nonbenzodiazepine hypnotic use and cases of "sleep driving"Mary Ross Southworth, Cindy Kortepeter, Alice Hughes
Journal of Clinical Pharmacology|July 22, 2014
Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it meansSudharshan Hariharan, Mary Ross Southworth, Rajanikanth Madabushi
The New England Journal of Medicine|March 15, 2013
Dabigatran and postmarketing reports of bleedingMary Ross Southworth, Marsha E Reichman, Ellis F Unger
Journal of the American College of Cardiology|January 15, 2025
Responder Analyses Can Be MisleadingMary Ross Southworth, Mitchell A Psotka, Jordan E Pomeroy, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2003
Treatment options for acute decompensated heart failureMary Ross Southworth
Therapeutic Innovation & Regulatory Science|September 21, 2018
Just Say No?Mary Ross Southworth, Norman Stockbridge
Therapeutic Innovation & Regulatory Science|March 15, 2026
Letter to the Editor: Battle Won but War Lost for Barth Syndrome PatientsNorman Stockbridge, Mary Ross Southworth
The New England Journal of Medicine|November 12, 2010
Interaction of clopidogrel and omeprazoleMary Ross Southworth, Robert Temple
The Journal of Cardiovascular Nursing|November 6, 2004
New treatment option for heart failure patients: eplerenoneMary Ross Southworth, Larisa H Cavallari
Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2019
Real World Data and Evidence: Support for Drug Approval: Applications to Kidney DiseasesAliza M Thompson, Mary Ross Southworth
Annals of Internal Medicine|March 19, 2008
Nonbenzodiazepine hypnotic use and cases of "sleep driving"Mary Ross Southworth, Cindy Kortepeter, Alice Hughes
Journal of Clinical Pharmacology|July 22, 2014
Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it meansSudharshan Hariharan, Mary Ross Southworth, Rajanikanth Madabushi
The New England Journal of Medicine|March 15, 2013
Dabigatran and postmarketing reports of bleedingMary Ross Southworth, Marsha E Reichman, Ellis F Unger
Journal of the American College of Cardiology|January 15, 2025
Responder Analyses Can Be MisleadingMary Ross Southworth, Mitchell A Psotka, Jordan E Pomeroy, et al.
Pageof 3